These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 3971637)

  • 1. Carbamazepine metabolism in man. Induction and pharmacogenetic aspects.
    Eichelbaum M; Tomson T; Tybring G; Bertilsson L
    Clin Pharmacokinet; 1985; 10(1):80-90. PubMed ID: 3971637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early stage autoinduction of carbamazepine metabolism in humans.
    Bernus I; Dickinson RG; Hooper WD; Eadie MJ
    Eur J Clin Pharmacol; 1994; 47(4):355-60. PubMed ID: 7875188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbamazepine-10,11-diol steady-state serum levels and renal excretion during carbamazepine therapy in adults and children.
    Bourgeois BF; Wad N
    Ther Drug Monit; 1984; 6(3):259-65. PubMed ID: 6506133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-dose kinetics and metabolism of carbamazepine-10,11-epoxide.
    Tomson T; Tybring G; Bertilsson L
    Clin Pharmacol Ther; 1983 Jan; 33(1):58-65. PubMed ID: 6848300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-dose kinetics of an enteric-coated formulation of carbamazepine-10,11-epoxide, an active metabolite of carbamazepine.
    Spina E; Tomson T; Svensson JO; Faigle JW; Bertilsson L
    Ther Drug Monit; 1988; 10(4):382-5. PubMed ID: 3201523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbamazepine-danazol drug interaction: its mechanism examined by a stable isotope technique.
    Krämer G; Theisohn M; von Unruh GE; Eichelbaum M
    Ther Drug Monit; 1986; 8(4):387-92. PubMed ID: 3824425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbamazepine: detection of another metabolite in serum, 9 hydroxymethyl-10-carbamoyl acridan.
    Wad N; Guenat C; Krämer G
    Ther Drug Monit; 1997 Jun; 19(3):314-7. PubMed ID: 9200773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacokinetics of carbamazepine and its epoxy and hydroxy metabolites in humans after an overdose.
    Vree TB; Janssen TJ; Hekster YA; Termond EF; van de Dries AC; Wijnands WJ
    Ther Drug Monit; 1986; 8(3):297-304. PubMed ID: 3750374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and metabolic investigation of topiramate disposition in healthy subjects in the absence and in the presence of enzyme induction by carbamazepine.
    Britzi M; Perucca E; Soback S; Levy RH; Fattore C; Crema F; Gatti G; Doose DR; Maryanoff BE; Bialer M
    Epilepsia; 2005 Mar; 46(3):378-84. PubMed ID: 15730535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics: time-dependent changes--autoinduction of carbamazepine epoxidation.
    Bertilsson L; Tomson T; Tybring G
    J Clin Pharmacol; 1986; 26(6):459-62. PubMed ID: 3734137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-dependent metabolism of carbamazepine in humans.
    Bernus I; Dickinson RG; Hooper WD; Eadie MJ
    Epilepsy Res; 1996 Jul; 24(3):163-72. PubMed ID: 8832192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haplotype structures of EPHX1 and their effects on the metabolism of carbamazepine-10,11-epoxide in Japanese epileptic patients.
    Nakajima Y; Saito Y; Shiseki K; Fukushima-Uesaka H; Hasegawa R; Ozawa S; Sugai K; Katoh M; Saitoh O; Ohnuma T; Kawai M; Ohtsuki T; Suzuki C; Minami N; Kimura H; Goto Y; Kamatani N; Kaniwa N; Sawada J
    Eur J Clin Pharmacol; 2005 Mar; 61(1):25-34. PubMed ID: 15692831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics and metabolism of carbamazepine during combined antiepileptic drug therapy.
    Eichelbaum M; Köthe KW; Hoffman F; von Unruh GE
    Clin Pharmacol Ther; 1979 Sep; 26(3):366-71. PubMed ID: 466929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of carbamazepine and carbamazepine-10,11-epoxide on hepatic cytochromes P450 in the rat.
    Panesar SK; Bandiera SM; Abbott FS
    Drug Metab Dispos; 1996 Jun; 24(6):619-27. PubMed ID: 8781776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microsomal metabolism of carbamazepine and oxcarbazepine in liver and placenta.
    Myllynen P; Pienimäki P; Raunio H; Vähäkangas K
    Hum Exp Toxicol; 1998 Dec; 17(12):668-76. PubMed ID: 9988371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbamazepine drug interactions: the influence of concurrent drug therapy on serum concentrations of carbamazepine and its epoxide metabolite.
    Wang RB; Liu LT; Yiu CH; Chang TY
    Zhonghua Yi Xue Za Zhi (Taipei); 1990 Apr; 45(4):222-32. PubMed ID: 2168269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daily variations in steady-state plasma concentrations of carbamazepine and its metabolites in epileptic children.
    Hartley R; Forsythe WI; McLain B; Ng PC; Lucock MD
    Clin Pharmacokinet; 1991 Mar; 20(3):237-46. PubMed ID: 2025982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the metabolites of carbamazepine in patient urine by liquid chromatography/mass spectrometry.
    Maggs JL; Pirmohamed M; Kitteringham NR; Park BK
    Drug Metab Dispos; 1997 Mar; 25(3):275-80. PubMed ID: 9172943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum concentrations of carbamazepine and its epoxide and diol metabolites in epileptic patients: the influence of dose and comedication.
    Rambeck B; May T; Juergens U
    Ther Drug Monit; 1987 Sep; 9(3):298-303. PubMed ID: 3672573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intradose and circadian variation in circulating carbamazepine and its epoxide in epileptic patients: a consequence of autoinduction of metabolism.
    Macphee GJ; Butler E; Brodie MJ
    Epilepsia; 1987; 28(3):286-94. PubMed ID: 3582293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.